Canadian middle-market private equity firm Bedford Capital has sold its portfolio company, L.B. Maple Treat, to Champlain Financial.
According to Bedford Capital, L.B. Maple Treat (LBMT) is one of the largest bottlers of branded and private label maple syrup in the world. It also sells maple syrup-related products including cookies, maple sugar and maple butter. The company is led by its president Luc Bergeron and is headquartered in Quebec (www.lbmapletreat.com).
Private equity firm Champlain Financial, the buyer of LBMT, invests in companies with EBITDAs ranging from $3 million to $10 million. Sectors of interest include consumer, retail distribution, healthcare and niche manufacturing. The firm is led by its managing partner Pierre Simard and is headquartered in Quebec (www.champlaincanada.com).
Bedford Capital invests from $5 million to $15 million of equity in companies that have EBITDAs from $2 million to $15 million. The firm prefers to be the majority investor but will invest in companies where they have a minority interest so long as there is an alignment of interest with management and other shareholders. In order to remain in close contact with the management teams of its portfolio companies, Bedford prefers companies with head offices located within three hours travel time from Toronto. The firm was founded in 1982 and is headquartered in Toronto (www.bedfordcapital.ca).
Toronto-based CCC Investment Banking (www.cccinvestmentbanking.com) was the financial advisor to LBMT. Bill Farrell, Managing Director, and Razmig Boghossian, Vice President, led the transaction for CCC.
© 2016 Private Equity Professional • 2-11-16